135 related articles for article (PubMed ID: 2439814)
21. Bopindolol in the treatment of moderate hypertension: a dose-response study.
Moleur P; Peyrieux JC; Luciani J; David D; Boissel JP
Fundam Clin Pharmacol; 1988; 2(5):431-40. PubMed ID: 2906897
[TBL] [Abstract][Full Text] [Related]
22. Influence of atenolol and bopindolol on circadian heart rate.
Fitscha P; Meisner W; Tiso B
J Cardiovasc Pharmacol; 1986; 8 Suppl 6():S51-4. PubMed ID: 2439821
[TBL] [Abstract][Full Text] [Related]
23. MIS (Multicentric Isradipine Study of antihypertensive therapy).
Widimský J; Dzúrik R; Fetkovská N; Balazovjech I; Kvasnicka J; Lupínek Z; Mayer O; Pidrman V
Cor Vasa; 1992; 34(1):4-14. PubMed ID: 1363224
[TBL] [Abstract][Full Text] [Related]
24. Bopindolol: long-term effects on blood pressure, renal function, plasma renin activity, and plasma aldosterone in mild-to-moderate essential hypertension.
Shohat J; Modan M; Rosenfeld JB
Fundam Clin Pharmacol; 1989; 3(1):53-8. PubMed ID: 2565862
[TBL] [Abstract][Full Text] [Related]
25. Bopindolol and atenolol in patients with stable angina pectoris. Double-blind randomized comparative trial.
Hertzeanu H; Shemesh J; Loidl AF; Kellermann JJ
Cardiology; 1989; 76(4):312-8. PubMed ID: 2572323
[TBL] [Abstract][Full Text] [Related]
26. [Antihypertensive effect of bopindolol on stroke-prone spontaneously hypertensive rats (SHRSP)].
Yamashita K; Shigematsu K; Maeda T; Ishida Y; Niwa M; Ozaki M
Nihon Yakurigaku Zasshi; 1989 Jan; 93(1):7-15. PubMed ID: 2565861
[TBL] [Abstract][Full Text] [Related]
27. Bopindolol. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy.
Harron DW; Goa KL; Langtry HD
Drugs; 1991 Jan; 41(1):130-49. PubMed ID: 1706984
[TBL] [Abstract][Full Text] [Related]
28. Bopindolol, pindolol, and atenolol in patients with chronic obstructive lung disease.
Dorow P; Schiess W
Klin Wochenschr; 1986 Apr; 64(8):366-9. PubMed ID: 2871220
[TBL] [Abstract][Full Text] [Related]
29. [Value of a blood pressure profile in evaluating 2 antihypertensive agents].
Abetel G; Mérier G; Karly M; Genoud A; Bousquet JC
Schweiz Med Wochenschr; 1984 Dec; 114(48):1746-9. PubMed ID: 6151741
[TBL] [Abstract][Full Text] [Related]
30. Haemodynamic effects of bopindolol and atenolol in coronary artery disease. A noninvasive study.
Rapola JM; Pellinen TJ; Toivonen L; Nieminen MS
Ann Med; 1990; 22(4):221-4. PubMed ID: 2248757
[TBL] [Abstract][Full Text] [Related]
31. Comparison of a new vasodilating beta-blocker, carvedilol, with atenolol in the treatment of mild to moderate essential hypertension.
Ruilope LM
Am J Hypertens; 1994 Feb; 7(2):129-36. PubMed ID: 7910028
[TBL] [Abstract][Full Text] [Related]
32. Plasma lipid fractions during long-term monotherapy with the ISA-containing beta-adrenoceptor blocker bopindolol in hypertensive patients.
Van Brummelen P; Bolli P; Koolen MI; Staehelin HB; Bühler FR
Br J Clin Pharmacol; 1984 Jan; 17(1):86-8. PubMed ID: 6691892
[TBL] [Abstract][Full Text] [Related]
33. [Treatment of hypertension with a fixed combination of bopindolol and chlorthalidone (Sandoretic)].
Widimský J; Lánská V; Hulínský V; Balazovjech I; Havlík V; Havránek P; Kroupa E; Nikodýmová L; Pátek F; Svítil F; Svihovcová P
Vnitr Lek; 1996 Apr; 42(4):223-8. PubMed ID: 8693706
[TBL] [Abstract][Full Text] [Related]
34. Antihypertensive effect of isradipine on blood pressure at rest and during exercise.
Dvorák I; Blaha M; Nĕmcová H
Am J Hypertens; 1991 Feb; 4(2 Pt 2):144S-146S. PubMed ID: 1673616
[TBL] [Abstract][Full Text] [Related]
35. [The effect of the blood pressure lowering effect of bopindolol (Sandonorm) in patients with mild and moderate hypertension].
Zsáry A; Káldi N; Kállay K
Orv Hetil; 1991 Sep; 132(39):2149-51. PubMed ID: 1681490
[TBL] [Abstract][Full Text] [Related]
36. Pharmacodynamic models of various beta blockers: an explanation for the long duration of action of bopindolol.
Grevel J
J Cardiovasc Pharmacol; 1986; 8 Suppl 6():S16-9. PubMed ID: 2439812
[TBL] [Abstract][Full Text] [Related]
37. Effects of chronic oral administration of a new beta-blocker, bopindolol, on serum lipoprotein concentrations and blood pressure of spontaneously hypertensive rats.
Ishihara T; Chin WP; Yoshida Y; Sun HT; Mitomi A; Ishibashi T; Tamura K; Imai S
Arch Int Pharmacodyn Ther; 1989; 302():145-57. PubMed ID: 2576891
[TBL] [Abstract][Full Text] [Related]
38. Comparison of bopindolol and atenolol in chronic stable angina pectoris.
Fitscha P; Meisner W; Tiso B
Eur J Clin Pharmacol; 1990; 38(1):81-4. PubMed ID: 1970300
[TBL] [Abstract][Full Text] [Related]
39. Haemodynamic effects of short-term treatment with bopindolol in essential hypertension.
Fitscha P; Meisner W; Brandstetter G; Tiso B
Eur J Clin Pharmacol; 1988; 34(4):411-3. PubMed ID: 2900146
[TBL] [Abstract][Full Text] [Related]
40. The clinical pharmacology of bopindolol, a new long-acting beta-adrenoceptor antagonist, in hypertension.
van den Meiracker AH; Man in 't Veld AJ; van Eck HJ; Boomsma F; Derkx FH; Mulder P; Schalekamp MA
Clin Pharmacol Ther; 1987 Oct; 42(4):411-9. PubMed ID: 2889554
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
